









Markets
/
Stocks
/
nasdaq-lfst
/

Lifestance Health Group Inc

LFST

6.075USD

-0.175-2.80%

Market hours （ET）Quotes delayed by 15 min

2.36BMarket Cap

LossP/E TTM



Lifestance Health Group Inc

6.075

-0.175-2.80%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Lifestance Health Group Inc

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Lifestance Health Group Inc's Score

Industry at a Glance

Industry Ranking

4 / 78

Overall Ranking

65 / 4615

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 8 analysts

Buy

Current Rating

8.333

Target Price

+73.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Lifestance Health Group Inc Highlights

StrengthsRisks

LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 45.54% year-on-year.

Undervalued

The company’s latest PE is -148.53, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 356.55M shares, decreasing 4.63% quarter-over-quarter.

Held by Steven Cohen

Star Investor Steven Cohen holds 1.92M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.93.

Financial Health

Currency: USD Updated: 2025-11-06

The company's current financial score is 6.89, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 345.31M, representing a year-over-year increase of 10.56%, while its net profit experienced a year-over-year increase of 83.71%.

Score

Industry at a Glance

Previous score

6.89

Change



Financials

9.27

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.49

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.52

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.01

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.17

Key Metrics

Free cash flow

No Data

Lifestance Health Group Inc's Company Valuation

Currency: USD Updated: 2025-11-06

The company’s current valuation score is 8.61, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is -148.53, which is -95.12% below the recent high of -7.25 and 0.00% above the recent low of -148.53.

Score

Industry at a Glance

Previous score

8.61

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 4/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-06

The company’s current earnings forecast score is 8.50, which is higher than the Healthcare Providers & Services industry's average of 7.56. The average price target for Lifestance Health Group Inc is 8.25, with a high of 10.00 and a low of 6.50.

Score

Industry at a Glance

Previous score

8.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 8 analysts

Buy

Current Rating

8.333

Target Price

+73.25%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

LifeStance Health Group Inc

LFST

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-06

The company’s current price momentum score is 9.31, which is higher than the Healthcare Providers & Services industry's average of 6.96. Sideways: Currently, the stock price is trading between the resistance level at 6.81 and the support level at 5.23, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.22

Change

3.09

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.130

Neutral

RSI(14)

72.307

Buy

STOCH(KDJ)(9,3,3)

57.135

Buy

ATR(14)

0.265

High Vlolatility

CCI(14)

349.783

Overbought

Williams %R

6.625

Overbought

TRIX(12,20)

-0.227

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

5.172

Buy

MA10

5.116

Buy

MA20

5.114

Buy

MA50

5.288

Buy

MA100

4.995

Buy

MA200

5.903

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-06

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 91.67%, representing a quarter-over-quarter decrease of 10.62%. The largest institutional shareholder is The Vanguard, holding a total of 12.20M shares, representing 3.14% of shares outstanding, with 12.63% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

TPG Capital, L.P.

160.71M

Summit Partners, L.P.

33.52M

-20.05%

Fidelity Management & Research Company LLC

23.08M

-18.07%

Silversmith Capital Partners

14.32M

-20.05%

The Vanguard Group, Inc.

Star Investors

12.20M

+9.01%

BlackRock Institutional Trust Company, N.A.

9.66M

-3.83%

Jennison Associates LLC

7.27M

-11.99%

Fidelity Institutional Asset Management

7.04M

+5.49%

Dimensional Fund Advisors, L.P.

6.57M

+36.19%

Brown Advisory

5.21M

-10.51%

Risk Assessment

Currency: USD Updated: 2025-11-06

The company’s current risk assessment score is 5.78, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.15. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.